Skip to main content

Table 3 Summary of results from all three follow-up of the same cohort

From: Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset

Mean follow-up time (years) from onset of uveitis

7.2

24.0

40.7

Mean age at follow-up (years)

13.2

31.0

46.9

Female sex (%)

34 (61.8)

29 (59.1)

16 (53.3)

Patients participating (% of original cohort)

55 (100)

49 (89.0)

30 (54.5)

EULAR a

 O

46

41

26

 P

6

5

2

 S

3

3

2

ANA at diagnosisb (% +)

40+ (72.2)

35+ (71.4)

23 + (76.6)

13-

12-

6-

2 u

2 u

1 u

Female sex with ANA+,

24

20

11

HLA-B27c (%+)

13+ (23.6)

13+ (26.5)

8+ (26.6)

29-

26-

18-

13 u

10 u

4 u

Female sex with HLA-B27 +,

5

5

2

Patients with active uveitisd (%)

28 (50.9)

27 (55.1)

13 (43.3)

Female sex with active uveitis

19

15

5

Number of patients with cataractse (%)

23 (41.8)

28 (57.1)

20 (66.6)

Female sex with cataracts

14

19

11

Number of patients with G/OHf (%)

3 (5.4)

12 (24.4)

12 (40.0)

Female sex with G/OH

2

5

5

Number of patients with severe visual impairment in both eyesg (%) of these, female sex

2 (3.6)

5 (10.2)

3 (10.0)

2

3

1

Number of single eyes with severe visual impairment g (%) of these, female sex

12 (10.9)

17 (17.3)

14 (23.3)

8

11

7

Number of patients with mild or no visual impairment in best eye (%) of these, female sex

49 (89.0)

29 (59.1)

20 (66.6)

30

19

11

Number of single eyes with mild or no visual impairment (%) of these, female sex

84 (76.3)

49 (50.0)

36 (60.0)

51

30

20

  1. Severe visual impairment is defined as a vision score of poorer than 0.1 (Snellen 20/200)
  2. Moderate visual impairment is defined as vision equal to or better than 0.1 and poorer than 0.3 (Snellen equal to or better than 20/200 and poorer than 20/70)
  3. Mild or no visual impairment is defined as vision equal to or better than 0.3 (Snellen 20/70)
  4. a EULAR diagnostic classification at onset of Juvenile Chronic Arthritis: O=oligoarthritis, P=polyarthritis, S=systemic disease
  5. b Number of patients who were ANA positive (+), negative (-) or unknown (u) at diagnosis of joint disease
  6. c HLA-B27 positive (+), negative (-) or unknown (u)
  7. d The difference in the incidences of active uveitis at 7, 24, and 40 years was not significant
  8. e The increase in the number of patients with cataracts between 7 years and 24 years was significant (p=0.001), while the difference between 24 years and 40 years was not (p=1.000)
  9. f The increase in the number of patients with G/OH was statistically significant between the 7-year follow-up and the 24-year follow-up (p=0.004), while the difference between 24 and 40 years was not (p=0.250)
  10. g According to the World Health Organization classification of visual impairment